Michael J. Keating

Statistics

Publications

Citations

431

H-Index

Active since

1991

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Michael J. Keating is an author at The University of Texas MD Anderson Cancer Center specializing in fludarabine-based regimens, chemotherapy, and clinical pharmacology.

Publications per year

1991–2024

Publications

Fludarabine and Arabinosylcytosine Therapy of Refractory and Relapsed Acute Myelogenous Leukemia

Elihu H. Estey, William Plunkett, Varsha Gandhi et al. · Leukemia & lymphoma/Leukemia and lymphoma · 1993 · 158 citations

Medicine, Oncology, Pharmacology +14

Allogeneic blood or marrow transplantation for chronic lymphocytic leukaemia: timing of transplantation and potential effect of fludarabine on acute graft‐versus‐host disease

Issa F. Khouri, Donna Przepiorka, Koen van Besien et al. · British Journal of Haematology · 1997 · 102 citations · Full text

Life Sciences, Hematology, Immunology +14

Fludarabine therapy in hairy cell leukemia

Hagop M. Kantarjian, Jay Schachner, Michael J. Keating · Cancer · 1991 · 60 citations

Medicine, Pharmacology, Pharmacotherapy +12

Sequential Cis-Platinum and Fludarabine with or without Arabinosyl Cytosine in Patients Failing Prior Fludarabine Therapy for Chronic Lymphocytic Leukemia: A Phase II Study

Francis J. Giles, Susan O’Brien, Valeria Santini et al. · Leukemia & lymphoma/Leukemia and lymphoma · 1999 · 35 citations

Pharmacy, Oncology, Pharmacotherapy +15

Detection of Subgroups of Chronic B-Cell Leukemias by FMC7 Monoclonal Antibody

Yang O. Huh, William Pugh, Hagop M. Kantarjian et al. · American Journal of Clinical Pathology · 1994 · 33 citations

Medicine, Hematology, Pathology +17

1–5 of 7